- Home
- ENTO vs AREB Comparison
ENTO vs AREB Comparison
Compare ENTO & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTO
- AREB
- Stock Information
- Founded
- ENTO 2014
- AREB 2014
- Country
- ENTO United States
- AREB United States
- Employees
- ENTO N/A
- AREB N/A
- Industry
- ENTO Biotechnology: Pharmaceutical Preparations
- AREB Plastic Products
- Sector
- ENTO Health Care
- AREB Industrials
- Exchange
- ENTO Nasdaq
- AREB Nasdaq
- Market Cap
- ENTO 2.5M
- AREB 2.8M
- IPO Year
- ENTO 2016
- AREB N/A
- Fundamental
- Price
- ENTO $0.41
- AREB $6.29
- Analyst Decision
- ENTO
- AREB
- Analyst Count
- ENTO 0
- AREB 0
- Target Price
- ENTO N/A
- AREB N/A
- AVG Volume (30 Days)
- ENTO 98.4K
- AREB 4.3M
- Earning Date
- ENTO 05-20-2025
- AREB 04-11-2025
- Dividend Yield
- ENTO N/A
- AREB N/A
- EPS Growth
- ENTO N/A
- AREB N/A
- EPS
- ENTO N/A
- AREB N/A
- Revenue
- ENTO N/A
- AREB $14,447,104.00
- Revenue This Year
- ENTO N/A
- AREB $45.19
- Revenue Next Year
- ENTO N/A
- AREB N/A
- P/E Ratio
- ENTO N/A
- AREB N/A
- Revenue Growth
- ENTO N/A
- AREB N/A
- 52 Week Low
- ENTO $0.19
- AREB $1.10
- 52 Week High
- ENTO $4.23
- AREB $231.75
- Technical
- Relative Strength Index (RSI)
- ENTO 37.79
- AREB 41.52
- Support Level
- ENTO $0.39
- AREB $1.10
- Resistance Level
- ENTO $0.61
- AREB $4.00
- Average True Range (ATR)
- ENTO 0.07
- AREB 1.46
- MACD
- ENTO -0.01
- AREB 0.95
- Stochastic Oscillator
- ENTO 8.93
- AREB 70.61
About ENTO Entero Therapeutics Inc. Common Stock
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.